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Abstract 
The aim of the study was to investigate the functional properties of extracts and utrafiltrates prepared from pig aorta tissues using 
Guinea pigs with an experimental atherosclerosis model to determine the possibility of their implementation against 
cardiovascular disorders. Serum total cholesterol content, atherogenic index (AI), low density lipoproteins (LDL) and residual 
cholesterol (VLDL, IDL) reduction was noted (44.1%, 43.7%, 43.7% and 79.5%, respectively) in animals treated with low-
molecular weight ultrafiltrate (LMU). Serum C-reactive protein (CRP) and Vascular endothelial growth factor (VEGF) 
concentrations declined by 34.0% and 58.3% on average, respectively in animals treated with LMU.  
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1. Introduction 
Nowadays, high technology is an important aspect of the food industry. The implementation of modern 
technologies and biological research results is an essential part of functional food development. Latest trends in 
healthy eating have led to a demand for a special line of products demands — functional foods. Bakery, dairy and 
meat industries are not only developing technology resulting in product with bio-corrective properties, but they are 
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also actively introducing received innovations. Various methods of intravital raw material modifications, genetic 
technologies and feed variations, plus food processing changes are used in the meat industry2,3,5,10,11. The proteomic 
approach is also being actively introduced. Meat is a functional system2 including protein, conjugated linoleic acid 
(CLA), minerals (iron, zinc and selenium), vitamins (B, E), glutathione, ubiquinone, lipoic acid etc.2,6,14. Moreover, 
the meat proteome is a source of bioactive sequences possessing hypotensive, antioxidant, opioid, 
immunomodulatory, prebiotic, mineral-binding, cholesterol-lowering or antimicrobial activity1,3,6,10,14. However, it 
should be noted that identification and the biological action of tissue-specific biological substances contained in 
meat by-products are still underdeveloped area. 
Atherosclerosis is a complex disease including lipid infiltration and general vascular wall inflammation7,13. For 
correction of this pathological condition not only must traditional serum lipid profile (cholesterol (LDL), 
triglycerides (TG), low density lipoprotein cholesterol (LDL), high density lipoproteins (HDL), atherogenic index 
(AI), the residual cholesterol) be evaluated, but markers of inflammation (CRP and VEGF) assessment should also 
be determined. The lipid-lowering, anti-inflammatory and antiatherosclerotic properties corresponding to native pig 
aorta extract and its ultrafiltrates in vivo are presented in this study.  
2. Materials and methods 
Aorta tissues were homogenized in a grinder KENWOOD (UK) with a hole diameter of 3-5 mm, re-frozen and 
then homogenized in a cutter KG Wetter 258/1336 (Germany) with the addition of distilled water in the ratio (4:1) 
and knife shaft speed of 2000 rpm. Then, homogenates were reconstituted in 0.9% NaCl solution, and extracted 
during 24 h, stirrer speed of 500 rpm. Extract separation was carried out by centrifugation for 7-10 minutes at 3,000-
3,500 rpm; centrifuge CM-6M (ELMI, Latvia). Supernatants were collected and ultrafiltered through PES 
membrane (MWCO 30kDa) by tangential filtration on the VivaFlow 200 system (Sartorius, Germany). Native 
extract, high-molecular weight ultrafiltrates (Mw>30kDa, HMU) were reconstituted in 0.9% NaCl solution to 
protein concentration 2.45g/l, low-molecular weight ultrafiltrates (Mw<30kDa, LMU) were lyophilized in INEY-4 
(IPB RAN, Russia) to protein concentration 2.45g/l.  
Fifty male Guinea pigs (580 ± 20 g) approximately 1 year old were kept in conventional standard conditions with 
an unlimited access to drinking water and feed. Animals were randomly divided in 5 groups: intact (n = 10); control 
(n = 10) and 1-3 experimental groups (ni =1-3 = 10). Hyperlipidemia and atherosclerosis were modeled in control and 
experimental animals by per os administration of cholesterol (0.5 g/kg b.w.) reconstituted in animal fat and vitamin 
D2 (35000 U/kg b.w.) during 21 days. After modeling, experimental animals were treated with extract, HMU and 
LMU (8 mg of protein/kg b.w.) per os: Then, 1 group animals were administered extract, 2 group – HMU, 3 group – 
LMU, while control group animals were administered 0.9% NaCl. At the end of the modeling, on the 14th day, 
Guinea pigs were euthanized in VETtech camera according to animal welfare rules, and blood samples for 
hematologic, biochemical and immunoassays investigations were taken. Biochemical investigations were carried out 
on a semiautomatic analyzer BioChem FC-360 (HTI, USA) according to instructions applied to measurement kits 
(HTI, USA); immunoassays were carried out on a microplate reader ImmunoChem 2100 (HTI, USA) with 
microplate thermoshaker ImmunoChem 2200 (HTI, USA) and microplate washer ImmunoChem 2600 (HTI, USA) 
according to the ELISA test (Cusabio, China).  
3. Results and discussion 
The most intensive cholesterol reduction, of 44.1%, was observed in Guinea pigs treated with LMU due to LDL 
level decrease by 43.7% in comparison with control animals on the 14th day. Residual cholesterol was significantly 
reduced by 53.8%, 66.7% and 79.5% in 1st, 2nd and 3rd experimental groups in comparison with control animals on 
the 14th day. This corresponds to lipid metabolism acceleration (Fig. 1). Serum AI declined by 24.0%, 34.4% and 
43.7% in 1st, 2nd and 3rd experimental groups on the 14th day in comparison with control (Fig. 2). 
 
 
 
52   Irina M. Chernukha et al. /  Procedia Food Science  5 ( 2015 )  50 – 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Serum lipid profile of experimental animals.                                       Fig. 2. Serum IA of experimental animals. 
CRP is synthesized in the liver. CRP is an acute phase protein involved in general atherosclerosis inflammation 
by attracting monocytes into atherosclerotic plaques zone by binding to a specific receptor. Therefore lowering CRP 
concentration in serum is directly correlated with a decrease of inflammation severity4,12. The greatest reduction of 
CRP in serum occurred in 3rd group animals treated with the LMU. CRP concentration was 0.99 ± 0.06 μg/ml, 
which was 34.0% lower than in the control group (Fig. 3). VEGF is a key regulator of the formation of microvessels. 
It promotes vasodilatation, increases vascular permeability, effect on the intensity of the inflammatory response and 
has many extravascular effects. Oncological processes, diabetes, rheumatoid arthritis, endometriosis, hypertension, 
atherosclerosis, and a number of other pathological conditions are accompanied by an increase in the concentration 
of VEGF in the blood and tissues8,13. The largest VEGF decrease was noted in serum of 3rd group animals treated 
with LMU, and reached 3.9 ± 0.97 pg/ml, which was 58.3% lower than in the control group (Fig. 4). 
 
 
 
 
 
 
 
 
 
Fig. 3. Serum CRP concentration.                                                               Fig. 4. Serum VEGF concentration. 
This study has shown that LMU produced the highest lipid lowering effect, leading to a decrease in the 
proportion of atherogenic lipoprotein fractions and an AI decrease. In addition, the VEGF and CRP concentration 
reduction could be indicators of vascular endothelium function normalization due to increasing defensive reaction. 
According to the results of this study, LMU is the most promising substance for further functional food production. 
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